Wednesday, August 10, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

BioWatch RFI – Trigger/Detector Capability

by Global Biodefense Staff
December 19, 2014
BioWatch Trigger Detector

The Department of Homeland Security (DHS) has issued a new Request for Information (RFI) in support of the BioWatch program.

The effort seeks to determine the current state of technologies that can provide a Biological Trigger/Detector added to the BioWatch sample collection process.

The item would be used in conjunction with current or future collection and identification technology and would serve to reduce the time to detect and improve BioWatch operational performance.

A successful candidate technology will have the ability to:

  • Detect indicators of potential biological agents within one minute
  • Detect these indicators at low concentrations with a high degree of confidence
  • Distinguish biological agent indicators from inorganic material and environmental background (dirt, brake dust, construction material, etc.)
  • Demonstrate a low rate of false positives and false negatives
  • Operate in a wide variety of indoor physical environments (e.g., office buildings, mass transit facilities), Ability to operate in outdoor environments
  • Transmit results and system status electronically and be controlled remotely

Further details are available via Solicitation Number: HSHQDC-15-I-11103. The response deadline is January 30, 2015.

Companion BioWatch RFIs were also simultaneously released for related areas including: Autonomous Indoor Sampling Systems, Portable Biological Identifier Systems, Aerosol Collection and Alternatives to PCR Detection.

Tags: BioterrorismBioWatchDHSHomeland SecurityRFISample Collection

Related Posts

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance
Biosurveillance

The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance

June 9, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Bacteria That Causes Melioidosis Confirmed in Environmental Samples in Mississippi Gulf Coast

Bacteria That Causes Melioidosis Confirmed in Environmental Samples in Mississippi Gulf Coast

July 27, 2022
Monkeypox Transmission: Virus Detected in Saliva, Bodily Fluids

Monkeypox Transmission: Virus Detected in Saliva, Bodily Fluids

July 17, 2022
Influenza Transmission Spikes During Social Gatherings

New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections

July 17, 2022
Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19

Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19

July 17, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC